FARIHA QADIR: Open Payments
NPI 1255343802 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,156 in 107 payments from 11 companies in 2025. Trend: 2023 $2,238 · 2024 $2,071 · 2025 $2,156
Food & beverage: $2,048Education: $108
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 18 | $352 |
| E.R. Squibb & Sons, L.L.C. | 19 | $336 |
| Alkermes, Inc. | 13 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $268 |
| Indivior Inc. | 8 | $222 |
| Teva Pharmaceuticals USA, Inc. | 9 | $200 |
| ABBVIE INC. | 9 | $171 |
| Vanda Pharmaceuticals Inc. | 8 | $159 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| Neurocrine BioSciences, Inc. | 3 | $61 |
Products named: COBENFY, CAPLYTA, REXULTI, SUBLOCADE, VRAYLAR, ARISTADA, FANAPT, VIVITROL.
Industry payments across MI — which companies pay providers there.
